PK

Purshottam Kant Bajpai

Active Director Director DIN 07257902
DIN 07257902 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Aug 2015
Shareholding value •••• Premium profile

About Purshottam Kant Bajpai

Data last updated:

Purshottam Kant Bajpai is a Director at Value Formulations Private Limited (since 2015), Director at Ultravalue Pharmaceuticals Private Limited (since 2022) and Director at Valuemoney Nidhi Limited (since 2021). The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹19.63 Cr; the largest is Value Formulations Private Limited at ₹9.88 Cr (FY 2024).

DIN 07257902
Primary Designation Director
Industry Pharma
First Appointment 12 Aug 2015
Oldest Company Age 15 yrs
Largest company Value Formulations Private Limited · ₹9.88 Cr (FY 2024)
Combined revenue ₹19.63 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Value Formulations Private Limited U51101UP2011PTC045719
Director12 Aug 20152011₹9.88 Cr (FY 2024)Active
Director10 Jun 20222022₹9.75 Cr (FY 2024)Active
Valuemoney Nidhi Limited U65929UP2021PLN141408
Director06 Feb 20212021Active

Directorship timeline

Open interactive timeline →
Value Formulations Private Limited
Ultravalue Pharmaceuticals Private Limited
Valuemoney Nidhi Limited
Premium access

Shareholding and investment profile for Purshottam Kant Bajpai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purshottam Kant Bajpai

Purshottam Kant Bajpai currently holds 3 directorships: Value Formulations Private Limited (Director, since 12 Aug 2015, revenue ₹9.88 Cr (FY 2024)); Ultravalue Pharmaceuticals Private Limited (Director, since 10 Jun 2022, revenue ₹9.75 Cr (FY 2024)); Valuemoney Nidhi Limited (Director, since 06 Feb 2021).

Purshottam Kant Bajpai was first appointed on 12 Aug 2015 as Director at Value Formulations Private Limited. The most recent appointment on record is 10 Jun 2022 at Ultravalue Pharmaceuticals Private Limited.

The 2 current companies of Purshottam Kant Bajpai that report revenue have a combined latest revenue of ₹19.63 Cr: Value Formulations Private Limited ₹9.88 Cr (FY 2024); Ultravalue Pharmaceuticals Private Limited ₹9.75 Cr (FY 2024).

The current boards of Purshottam Kant Bajpai's companies include Vineeta Bajpai (Value Formulations Private Limited), Amit Kumar Anit (Ultravalue Pharmaceuticals Private Limited), Lalan Singh (Ultravalue Pharmaceuticals Private Limited), Mahesh Prasad Singh (Ultravalue Pharmaceuticals Private Limited), Rakesh Kumar (Ultravalue Pharmaceuticals Private Limited), Neeraj Kumar Misra (Valuemoney Nidhi Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available